Clinical Trial Update: Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting immunogenicity and safety data for the Hepavax-Gene TF hepatitis B vaccine in newborns, compared with a comparator hepatitis B va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B vaccine (comparator)
• Hepavax-Gene TF

Snippet

Sponsor: Crucell Holland BV | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED